UKVIA warns of heavy fines for e-cigarette use in Qatar

Nov.24.2022
UKVIA warns of heavy fines for e-cigarette use in Qatar
UK world cup fans are warned that vaping is illegal in Qatar and could result in steep fines.

The UK Vaping Industry Association (UKVIA) has issued a warning that England football fans could face hefty fines for violating Qatar's ban on electronic cigarettes. It has cautioned travelling fans that the restriction will be strictly enforced inside and around all eight tournament venues, and that if caught vaping during their visit, they could face severe penalties.


Using e-cigarettes in Qatar is illegal and can result in a maximum fine of 10,000 riyals (approximately £2,200) or a maximum of three months imprisonment. Fans hope to ensure they do not break the law.


The UK Vaping Industry Association (UKVIA) is issuing a warning to the estimated 20,000 English and Welsh football fans set to travel, urging them not to break the country's strict laws.


The UKVIA is concerned that an electronic cigarette ban would not only ruin the travel plans of anyone who vapes, but could also result in many people reverting back to smoking since cigarettes are still legal in Qatar.


During the World Cup, smoking and electronic cigarettes will be banned in all eight sports stadiums in Doha.


While the excitement builds ahead of the opening game of the 32 teams competing in the World Cup, there is another lesser-known team facing a ban.


Statement:


This article is compiled from third-party information and is intended for industry communication and learning purposes only.


The opinions expressed in this article do not necessarily reflect those of 2FIRSTS and 2FIRSTS cannot confirm the authenticity or accuracy of the article's content. The translation of this article is intended for industry communication and research purposes only.


Due to limitations in the level of compilation, the translated article may not fully reflect the original text. Please refer to the original text as the accurate source.


2FIRSTS aligns completely with the Chinese government's positions and statements on domestic, Hong Kong, Macau, Taiwan, and foreign affairs.


The compilation of information is the property of the original media and author. If there is any infringement, please contact us to have it removed.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

France’s ANSES Report Reframes the Vape Debate: Harm Reduction Confirmed, Regulatory Barriers Rising
France’s ANSES Report Reframes the Vape Debate: Harm Reduction Confirmed, Regulatory Barriers Rising
France’s top health agency has confirmed that vaping is less harmful than smoking — but not risk-free — reshaping the country’s regulatory trajectory. As Paris withdraws a proposed vape tax and debates stricter ingredient, emissions and youth-protection rules, the ANSES report signals not prohibition, but tighter technical oversight. For manufacturers, retailers and EU policymakers, France may be previewing Europe’s next phase of nicotine governance.
Special Report
Feb.23
Finnish Customs Investigate Firm Suspected of Importing and Selling Nicotine Pouches Without Paying Tobacco Tax
Finnish Customs Investigate Firm Suspected of Importing and Selling Nicotine Pouches Without Paying Tobacco Tax
Finnish Customs are investigating a firm suspected of importing and selling nicotine pouches without paying tobacco tax. Two Finnish citizens have been questioned as part of the probe. The authority believes the nicotine pouches were imported into Finland from other EU countries before being distributed to Finnish retailers.
Mar.11 by 2FIRSTS.ai
South Dakota Senate Committee Advances Bill Tightening Nicotine Retail Rules
South Dakota Senate Committee Advances Bill Tightening Nicotine Retail Rules
South Dakota Senate Bill 221 (SB 221), which seeks to regulate the retail sale of nicotine products, has passed the Senate Health and Human Services Committee with a unanimous 7–0 recommendation. The bill was significantly amended, expanding from three to nine pages and shifting its focus from vapor products alone to all nicotine products.
Regulations
Feb.22
Russia’s Volgograd Police Seize Illicit Nicotine Products Worth Over US$42.9K+
Russia’s Volgograd Police Seize Illicit Nicotine Products Worth Over US$42.9K+
Police in Russia’s Volgograd region say they seized nicotine products lacking mandatory markings valued at more than RUB 3.3 million (about US$42,900+, using RUB 1 = US$0.013). A 43-year-old suspect allegedly stored and sold the products through two retail outlets in Volgograd’s Central and Dzerzhinsky districts. A criminal case has been opened under Article 171.1(6) of the Russian Criminal Code.
Jan.30 by 2FIRSTS.ai
Ireland’s 2026 amendment bill to regulate nicotine pouches and tighten rules on vaping products
Ireland’s 2026 amendment bill to regulate nicotine pouches and tighten rules on vaping products
The Irish government has approved the publication of the Public Health (Tobacco Products and Nicotine Inhaling Products) (Amendment) Bill 2026. The bill would ban the sale of nicotine consumption products such as nicotine pouches to those under 18 and further regulate nicotine vaping products.
Mar.05 by 2FIRSTS.ai
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
U.S.-based medical startup Qnovia Inc. reported positive results from its first-in-human clinical trial of RespiRx, an inhalable nicotine replacement therapy (NRT) device designed to support smoking cessation.
Innovation
Feb.24